世界の急性リンパ芽球性白血病薬市場2026:インサイト・予測

QYResearchが発行した調査報告書(QYR20NV02087)
◆英語タイトル:Global Acute Lymphoblastic Leukemia Drug Market Insights and Forecast to 2026
◆商品コード:QYR20NV02087
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年11月(※2024年版があります。お問い合わせください。)
◆ページ数:112
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは急性リンパ芽球性白血病薬の世界市場について調査・分析した資料です。種類別(経口、非経口)の市場規模、用途別(病院、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別急性リンパ芽球性白血病薬の競争状況、市場シェア
・世界の急性リンパ芽球性白血病薬市場:種類別市場規模 2015年-2020年(経口、非経口)
・世界の急性リンパ芽球性白血病薬市場:種類別市場規模予測 2021年-2026年(経口、非経口)
・世界の急性リンパ芽球性白血病薬市場:用途別市場規模 2015年-2020年(病院、その他)
・世界の急性リンパ芽球性白血病薬市場:用途別市場規模予測 2021年-2026年(病院、その他)
・北米の急性リンパ芽球性白血病薬市場分析:米国、カナダ
・ヨーロッパの急性リンパ芽球性白血病薬市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの急性リンパ芽球性白血病薬市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の急性リンパ芽球性白血病薬市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの急性リンパ芽球性白血病薬市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Otsuka、Ono Pharmaceuticals、Amgen、Bristol-Myers Squibb、Novartis、Boehringer Ingelheim
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Market Analysis and Insights: Global Acute Lymphoblastic Leukemia Drug Market
The global Acute Lymphoblastic Leukemia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Acute Lymphoblastic Leukemia Drug Scope and Market Size
Acute Lymphoblastic Leukemia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Acute Lymphoblastic Leukemia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Acute Lymphoblastic Leukemia Drug market is segmented into
Oral
Parenteral

Segment by Application, the Acute Lymphoblastic Leukemia Drug market is segmented into
Hospital
Other medical institutions

Regional and Country-level Analysis
The Acute Lymphoblastic Leukemia Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Acute Lymphoblastic Leukemia Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Acute Lymphoblastic Leukemia Drug Market Share Analysis
Acute Lymphoblastic Leukemia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Acute Lymphoblastic Leukemia Drug business, the date to enter into the Acute Lymphoblastic Leukemia Drug market, Acute Lymphoblastic Leukemia Drug product introduction, recent developments, etc.

The major vendors covered:
Otsuka
Ono Pharmaceuticals
Amgen
Bristol-Myers Squibb
Novartis
Boehringer Ingelheim

【レポートの目次】

1 Study Coverage
1.1 Acute Lymphoblastic Leukemia Drug Product Introduction
1.2 Market Segments
1.3 Key Acute Lymphoblastic Leukemia Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Acute Lymphoblastic Leukemia Drug Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Acute Lymphoblastic Leukemia Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Other medical institutions
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Acute Lymphoblastic Leukemia Drug Market Size, Estimates and Forecasts
2.1.1 Global Acute Lymphoblastic Leukemia Drug Revenue 2015-2026
2.1.2 Global Acute Lymphoblastic Leukemia Drug Sales 2015-2026
2.2 Global Acute Lymphoblastic Leukemia Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Acute Lymphoblastic Leukemia Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Acute Lymphoblastic Leukemia Drug Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Acute Lymphoblastic Leukemia Drug Competitor Landscape by Players
3.1 Acute Lymphoblastic Leukemia Drug Sales by Manufacturers
3.1.1 Acute Lymphoblastic Leukemia Drug Sales by Manufacturers (2015-2020)
3.1.2 Acute Lymphoblastic Leukemia Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Acute Lymphoblastic Leukemia Drug Revenue by Manufacturers
3.2.1 Acute Lymphoblastic Leukemia Drug Revenue by Manufacturers (2015-2020)
3.2.2 Acute Lymphoblastic Leukemia Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Acute Lymphoblastic Leukemia Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Acute Lymphoblastic Leukemia Drug Revenue in 2019
3.2.5 Global Acute Lymphoblastic Leukemia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Acute Lymphoblastic Leukemia Drug Price by Manufacturers
3.4 Acute Lymphoblastic Leukemia Drug Manufacturing Base Distribution, Product Types
3.4.1 Acute Lymphoblastic Leukemia Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Acute Lymphoblastic Leukemia Drug Product Type
3.4.3 Date of International Manufacturers Enter into Acute Lymphoblastic Leukemia Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Acute Lymphoblastic Leukemia Drug Market Size by Type (2015-2020)
4.1.1 Global Acute Lymphoblastic Leukemia Drug Sales by Type (2015-2020)
4.1.2 Global Acute Lymphoblastic Leukemia Drug Revenue by Type (2015-2020)
4.1.3 Acute Lymphoblastic Leukemia Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Acute Lymphoblastic Leukemia Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Acute Lymphoblastic Leukemia Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Acute Lymphoblastic Leukemia Drug Revenue Forecast by Type (2021-2026)
4.2.3 Acute Lymphoblastic Leukemia Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Acute Lymphoblastic Leukemia Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Acute Lymphoblastic Leukemia Drug Market Size by Application (2015-2020)
5.1.1 Global Acute Lymphoblastic Leukemia Drug Sales by Application (2015-2020)
5.1.2 Global Acute Lymphoblastic Leukemia Drug Revenue by Application (2015-2020)
5.1.3 Acute Lymphoblastic Leukemia Drug Price by Application (2015-2020)
5.2 Acute Lymphoblastic Leukemia Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Acute Lymphoblastic Leukemia Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Acute Lymphoblastic Leukemia Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Acute Lymphoblastic Leukemia Drug Price Forecast by Application (2021-2026)

6 North America
6.1 North America Acute Lymphoblastic Leukemia Drug by Country
6.1.1 North America Acute Lymphoblastic Leukemia Drug Sales by Country
6.1.2 North America Acute Lymphoblastic Leukemia Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Type
6.3 North America Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Application

7 Europe
7.1 Europe Acute Lymphoblastic Leukemia Drug by Country
7.1.1 Europe Acute Lymphoblastic Leukemia Drug Sales by Country
7.1.2 Europe Acute Lymphoblastic Leukemia Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Type
7.3 Europe Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Acute Lymphoblastic Leukemia Drug by Region
8.1.1 Asia Pacific Acute Lymphoblastic Leukemia Drug Sales by Region
8.1.2 Asia Pacific Acute Lymphoblastic Leukemia Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Type
8.3 Asia Pacific Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Application

9 Latin America
9.1 Latin America Acute Lymphoblastic Leukemia Drug by Country
9.1.1 Latin America Acute Lymphoblastic Leukemia Drug Sales by Country
9.1.2 Latin America Acute Lymphoblastic Leukemia Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Type
9.3 Central & South America Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Acute Lymphoblastic Leukemia Drug by Country
10.1.1 Middle East and Africa Acute Lymphoblastic Leukemia Drug Sales by Country
10.1.2 Middle East and Africa Acute Lymphoblastic Leukemia Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Type
10.3 Middle East and Africa Acute Lymphoblastic Leukemia Drug Market Facts & Figures by Application

11 Company Profiles
11.1 Otsuka
11.1.1 Otsuka Corporation Information
11.1.2 Otsuka Description and Business Overview
11.1.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Otsuka Acute Lymphoblastic Leukemia Drug Products Offered
11.1.5 Otsuka Related Developments
11.2 Ono Pharmaceuticals
11.2.1 Ono Pharmaceuticals Corporation Information
11.2.2 Ono Pharmaceuticals Description and Business Overview
11.2.3 Ono Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Ono Pharmaceuticals Acute Lymphoblastic Leukemia Drug Products Offered
11.2.5 Ono Pharmaceuticals Related Developments
11.3 Amgen
11.3.1 Amgen Corporation Information
11.3.2 Amgen Description and Business Overview
11.3.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen Acute Lymphoblastic Leukemia Drug Products Offered
11.3.5 Amgen Related Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Corporation Information
11.4.2 Bristol-Myers Squibb Description and Business Overview
11.4.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bristol-Myers Squibb Acute Lymphoblastic Leukemia Drug Products Offered
11.4.5 Bristol-Myers Squibb Related Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description and Business Overview
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Acute Lymphoblastic Leukemia Drug Products Offered
11.5.5 Novartis Related Developments
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Corporation Information
11.6.2 Boehringer Ingelheim Description and Business Overview
11.6.3 Boehringer Ingelheim Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Boehringer Ingelheim Acute Lymphoblastic Leukemia Drug Products Offered
11.6.5 Boehringer Ingelheim Related Developments
11.1 Otsuka
11.1.1 Otsuka Corporation Information
11.1.2 Otsuka Description and Business Overview
11.1.3 Otsuka Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Otsuka Acute Lymphoblastic Leukemia Drug Products Offered
11.1.5 Otsuka Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Acute Lymphoblastic Leukemia Drug Market Estimates and Projections by Region
12.1.1 Global Acute Lymphoblastic Leukemia Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Acute Lymphoblastic Leukemia Drug Revenue Forecast by Regions 2021-2026
12.2 North America Acute Lymphoblastic Leukemia Drug Market Size Forecast (2021-2026)
12.2.1 North America: Acute Lymphoblastic Leukemia Drug Sales Forecast (2021-2026)
12.2.2 North America: Acute Lymphoblastic Leukemia Drug Revenue Forecast (2021-2026)
12.2.3 North America: Acute Lymphoblastic Leukemia Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Acute Lymphoblastic Leukemia Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Acute Lymphoblastic Leukemia Drug Sales Forecast (2021-2026)
12.3.2 Europe: Acute Lymphoblastic Leukemia Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Acute Lymphoblastic Leukemia Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Acute Lymphoblastic Leukemia Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Acute Lymphoblastic Leukemia Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Acute Lymphoblastic Leukemia Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Acute Lymphoblastic Leukemia Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Acute Lymphoblastic Leukemia Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Acute Lymphoblastic Leukemia Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Acute Lymphoblastic Leukemia Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Acute Lymphoblastic Leukemia Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Acute Lymphoblastic Leukemia Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Acute Lymphoblastic Leukemia Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Acute Lymphoblastic Leukemia Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Acute Lymphoblastic Leukemia Drug Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Acute Lymphoblastic Leukemia Drug Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Acute Lymphoblastic Leukemia Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

...

【掲載企業】

Otsuka、Ono Pharmaceuticals、Amgen、Bristol-Myers Squibb、Novartis、Boehringer Ingelheim

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の急性リンパ芽球性白血病薬市場2026:インサイト・予測(Global Acute Lymphoblastic Leukemia Drug Market Insights and Forecast to 2026)]についてメールでお問い合わせはこちらでお願いします。